Idexx Laboratories Inc

Idexx Laboratories Inc

Compare this stock

IDXX Stock Report Card

$

VolatilityTechnicalsProfitPerformanceEarningsAnalyst Price Targets

80%

Performance

Score:

100/100

IDXX returned 4.38% in the last 12 months. Based on SPY's performance of -13.50%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

Score:

73/100

10 analysts offer 12-month price targets for IDXX. Together, they have an average target of 478.5, the most optimistic target put IDXX at 600 within 12-months and the most pessimistic has IDXX at 247.

Technicals

Score:

61/100

IDXX receives a 60 of 100 based on 14 indicators. 8 are bullish, 5 are bearish.

Earnings

Score:

100/100

IDXX has missed earnings 0 times in the last 20 quarters.

Profit

Score:

84/100

Out of the last 20 quarters, IDXX has had 20 profitable quarters and has increased their profits year over year on 12 of them.

Volatility

Score:

53/100

IDXX has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.

Idexx Laboratories Inc Summary

Nasdaq / IDXX
Healthcare
Diagnostics & Research
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.